http://www.onemedplace.com/blog/wp-content/uploads/2009/05/dollars.jpg
While biotech leaders from all over the world gathered at the 2009 BIO International Convention in Atlanta, financing activity in the sector raised hope that the cloud hanging over the industry may be...
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/07/redbloodcells.jpg
Most people have never heard of myelodysplastic syndrome (MDS), but approximately 10,000 to 15,000 people in the U.S. are diagnosed with it every year.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/05/pillsmoney.jpg
The Nasdaq rose 5 points on Monday, due in part to recent happenings in the biopharmaceutical sector.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/10/myeloma.jpg
Onyx Pharmaceuticals has agreed to purchase private biotechnology company Proteolix for $276 million in cash.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/12/biotechdollars.jpg
Biopharmaceutical company Celgene is plumping up its oncology pipeline with its latest acquisition.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2009/12/antibiotics.jpg
Cubist Pharmaceuticals has announced plans to acquire tiny San Diego biotech Calixa Therapeutics for up to $402.5 million.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/07/handshake2.jpg
Celgene has acquired Abraxis BioScience in a cash-and-stock deal valued at $2.9 billion, reports FierceBiotech.
View Article
